PharmiWeb.com - Global Pharma News & Resources
15-Aug-2025

GenesisCare Further Expands Its Adaptive Radiotherapy MR Linac Network

GenesisCare Further Expands Its Adaptive Radiotherapy MR Linac Network

 

GenesisCare, the UK’s leading independent cancer care provider, announces the expansion of their adaptive radiotherapy network with the launch of their third state-of-the-art MR Linac in Guildford, Surrey. This continues their commitment to offering the most advanced, evidence-based cancer treatments to patients throughout the UK and beyond. Since the Oxford launch of their MR-linac service in 2019, GenesisCare has treated over 2000 patients, making them the most experienced provider of this cutting-edge treatment in the UK.

 

This advanced radiotherapy technology dynamically adjusts radiation delivery in real-time to precisely match the individual patient’s anatomy, enhancing tumour control while minimising side effects r. This is particularly important for complex cancers such as inoperable pancreatic, lung, and abdominal tumours, as well as simultaneous treatment of multiple secondary tumours. The treatment also allows clinicians to deliver repeat radiotherapy for recurrent cancers providing patients with a safe and effective alternative to chemotherapy, hormone therapy and surgery.

 

Alongside the existing MR-linac centres in Oxford and London, and with an ongoing commitment to clinical trials, the new facility in Guildford puts GenesisCare among the leading providers of MRI-guided radiotherapy globally.  They also operate 14 state-of-the-art cancer treatment centres throughout the UK, with their 15th centre set to open in Leeds in 2026.

 

Dr Sheena Khanduri, Chief Medical Officer at GenesisCare explains: “Adaptive radiotherapy represents a transformative advancement in cancer treatment. By using the technology’s ability to provide live images of both the tumour and normal tissue, we can create a new treatment plan every day based on the patient’s anatomy. This gives our clinicians the confidence to deliver high dose radiotherapy with exquisite precision, whilst minimising side effects, thereby improving patient outcomes. This is truly personalised radiotherapy." 

 

At no extra cost to the patient or insurance provider, personalised treatment plans include complimentary therapies such as exercise medicine, a sleep & menopause programme, and on-site holistic support services. This reflects GenesisCare’s strong commitment to treating the whole patient, not just the cancer. 

  

Editor Details

Last Updated: 15-Aug-2025